Lot quality assurance sampling to assess coverage and compliance following mass drug administration to eliminate lymphatic filariasis in Fiji : a methodological approach

Reports on the first national assessment of lymphatic filariasis mass drug administration (LF-MDA) program coverage in Fiji, which used lot quality assurance sampling (LQAS) as a unique methodologic approach not only to obtain programmatic information on areas with low program coverage but also to e...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2020-09, Vol.15 (9), p.e0238622-e0238622
Main Author: Rinamalo, Milika
Format: Article
Language:English
Subjects:
Administration
Antigens
Biology and Life Sciences
Compliance auditing
Divisions
Drug dosages
Drug therapy
Drugs
Earth Sciences
Epidemiology
Evaluation
Filariasis
Health facilities
Health sciences
Health services
Islands
Medical policy
Medicine
Medicine and Health Sciences
Nursing
Patient compliance
People and Places
Population
Prevention
Public health
Public health administration
Quality assessment
Quality assurance
Quality control
Research and Analysis Methods
Sample size
Sampling
Supervision
Tropical diseases
Vector-borne diseases
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Reports on the first national assessment of lymphatic filariasis mass drug administration (LF-MDA) program coverage in Fiji, which used lot quality assurance sampling (LQAS) as a unique methodologic approach not only to obtain programmatic information on areas with low program coverage but also to explore issues affecting the overall LF-MDA implementation strategy at the national level. Source: National Library of New Zealand Te Puna Matauranga o Aotearoa, licensed by the Department of Internal Affairs for re-use under the Creative Commons Attribution 3.0 New Zealand Licence.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0238622